Jean‐Luc Pagani
- Infectious Diseases top 2%
- Antifungal resistance and susceptibility 14
- COVID-19 Clinical Research Studies 4
-
- Antibiotic Use and Resistance 4
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 4
- Epidemiology top 5%
- Sepsis Diagnosis and Treatment 7
- Pneumocystis jirovecii pneumonia detection and treatment 6
-
- Nosocomial Infections in ICU 4
-
- HIV/AIDS oral health manifestations 4
- Co-authors
- Jacques BilléFrançoise IscherKarl KuchlerMichel MonodDominique SanglardPhilippe EggimannYok‐Ai QueJean‐Pierre Revelly
- Journals
- Antimicrobial Agents and Chemotherapy (4 papers)Journal of Clinical Microbiology (4 papers)Burns (2 papers)
- Partner nations
- SwitzerlandFranceUnited States
In The Last Decade
Jean‐Luc Pagani
36 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Infectious Diseases 943
- Applied Microbiology and Biotechnology 87
- Molecular Medicine 155
- Epidemiology 792
- Critical Care and Intensive Care Medicine 66
Countries citing papers authored by Jean‐Luc Pagani
This map shows the geographic impact of Jean‐Luc Pagani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Luc Pagani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Luc Pagani more than expected).
Fields of papers citing papers by Jean‐Luc Pagani
This network shows the impact of papers produced by Jean‐Luc Pagani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Luc Pagani. The network helps show where Jean‐Luc Pagani may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jean‐Luc Pagani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 0 | |
| 5 | 2022 | 9 | |
| 6 | 2022 | 3 | |
| 7 | 2021 | 38 | |
| 8 | 2020 | 124 | |
| 9 | 2019 | 26 | |
| 10 | 2015 | 26 | |
| 11 | 2015 | 24 | |
| 12 | 2015 | 13 | |
| 13 | 2014 | 55 | |
| 14 | 2014 | 59 | |
| 15 | 2014 | 11 | |
| 16 | 2009 | 8 | |
| 17 | 2008 | 12 | |
| 18 | 2002 | 22 | |
| 19 | 2001 | 15 | |
| 20 | 1997 | 15 |
About Jean‐Luc Pagani
Jean‐Luc Pagani is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases, Molecular Medicine, Critical Care and Intensive Care Medicine and Epidemiology, having authored 37 papers that have together received 1.5k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (14 papers), Sepsis Diagnosis and Treatment (7 papers), Pneumocystis jirovecii pneumonia detection and treatment (6 papers), Antibiotic Use and Resistance (4 papers), Antibiotic Resistance in Bacteria (4 papers), COVID-19 Clinical Research Studies (4 papers), Nosocomial Infections in ICU (4 papers) and HIV/AIDS oral health manifestations (4 papers). The work is most often cited by research in Infectious Diseases (943 citations), Applied Microbiology and Biotechnology (87 citations), Molecular Medicine (155 citations), Epidemiology (792 citations) and Critical Care and Intensive Care Medicine (66 citations). Jean‐Luc Pagani has collaborated with scholars based in Switzerland, France and United States. Frequent co-authors include Jacques Billé, Françoise Ischer, Karl Kuchler, Michel Monod, Dominique Sanglard, Philippe Eggimann, Yok‐Ai Que, Jean‐Pierre Revelly, Patrick Boerlin and J. P. Chave. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Clinical Microbiology, Burns, Journal of Critical Care and Critical Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.